National trends in the treatment of diabetic nephropathy in the United States.
What is known and objective The prevalence of diabetic nephropathy continues to rise and it remains a strong predictor of morbidity and mortality in diabetic patients. Patients diagnosed with diabetic nephropathy are actively excluded from most trials involving diabetic medications and it is importa...
| Publicado en: | Journal of Clinical Pharmacy & Therapeutics Vol. 42; no. 3; pp. 311 - 318 |
|---|---|
| Autores principales: | , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Wiley-Blackwell
Jun2017
|
| Acceso en línea: | Ver este registro en EBSCOhost |